(Q47421779)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27281424%20AND%20SRC:MED&resulttype=core&format=json

13 March 2020

title

The US regulatory and pharmacopeia response to the global heparin contamination crisis (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27281424%20AND%20SRC:MED&resulttype=core&format=json

13 March 2020

1 reference

Anita Y Szajek

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27281424%20AND%20SRC:MED&resulttype=core&format=json

13 March 2020

Edward Chess

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27281424%20AND%20SRC:MED&resulttype=core&format=json

13 March 2020

Kristian Johansen

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27281424%20AND%20SRC:MED&resulttype=core&format=json

13 March 2020

Gyöngyi Gratzl

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27281424%20AND%20SRC:MED&resulttype=core&format=json

13 March 2020

Elaine Gray

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27281424%20AND%20SRC:MED&resulttype=core&format=json

13 March 2020

Jian Liu

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27281424%20AND%20SRC:MED&resulttype=core&format=json

13 March 2020

Tina Morris

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27281424%20AND%20SRC:MED&resulttype=core&format=json

13 March 2020

Barbara Mulloy

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27281424%20AND%20SRC:MED&resulttype=core&format=json

13 March 2020

Moheb Nasr

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27281424%20AND%20SRC:MED&resulttype=core&format=json

13 March 2020

Zachary Shriver

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27281424%20AND%20SRC:MED&resulttype=core&format=json

13 March 2020

Pearle Torralba

13

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27281424%20AND%20SRC:MED&resulttype=core&format=json

13 March 2020

Christian Viskov

14

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27281424%20AND%20SRC:MED&resulttype=core&format=json

13 March 2020

Roger Williams

15

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27281424%20AND%20SRC:MED&resulttype=core&format=json

13 March 2020

Wesley Workman

17

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27281424%20AND%20SRC:MED&resulttype=core&format=json

13 March 2020

Ali Al-Hakim

18

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27281424%20AND%20SRC:MED&resulttype=core&format=json

13 March 2020

Robert J Linhardt

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27281424%20AND%20SRC:MED&resulttype=core&format=json

13 March 2020

publication date

1 June 2016

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27281424%20AND%20SRC:MED&resulttype=core&format=json

13 March 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27281424%20AND%20SRC:MED&resulttype=core&format=json

13 March 2020

volume

34

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27281424%20AND%20SRC:MED&resulttype=core&format=json

13 March 2020

issue

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27281424%20AND%20SRC:MED&resulttype=core&format=json

13 March 2020

page(s)

625-630

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27281424%20AND%20SRC:MED&resulttype=core&format=json

Recent progress and applications in glycosaminoglycan and heparin research

13 March 2020

cites work

1 reference

'Heparin'--from anticoagulant drug into the new biology.

21 January 2018

1 reference

1976-1983, a critical period in the history of heparin: the discovery of the antithrombin binding site

21 January 2018

1 reference

21 January 2018

1 reference

Outbreak of adverse reactions associated with contaminated heparin

21 January 2018

1 reference

Contaminated heparin associated with adverse clinical events and activation of the contact system

21 January 2018

1 reference

Oversulfated chondroitin sulfate is a contaminant in heparin associated with adverse clinical events

21 January 2018

1 reference

Lessons learned from the contamination of heparin

21 January 2018

1 reference

Structure and physicochemical characterisation of heparin

21 January 2018

1 reference

A strategy for rapid sequencing of heparan sulfate and heparin saccharides

21 January 2018

1 reference

Chemoenzymatic synthesis of heparan sulfate and heparin

21 January 2018

1 reference

Sulfation patterns determine cellular internalization of heparin-like polysaccharides

21 January 2018

1 reference

Characterization of currently marketed heparin products: key tests for quality assurance

21 January 2018

1 reference

Effects on molecular conformation and anticoagulant activities of 1,6-anhydrosugars at the reducing terminal of antithrombin-binding octasaccharides isolated from low-molecular-weight heparin enoxaparin.

21 January 2018

1 reference

The interaction of enoxaparin and fondaparinux with calcium

21 January 2018

1 reference

Characterization of currently marketed heparin products: key tests for LMWH quality assurance.

21 January 2018

1 reference

Analysis of pharmaceutical heparins and potential contaminants using (1)H-NMR and PAGE.

21 January 2018

1 reference

Characterization of currently marketed heparin products: analysis of molecular weight and heparinase-I digest patterns.

21 January 2018

1 reference

USP compendial methods for analysis of heparin: chromatographic determination of molecular weight distributions for heparin sodium

21 January 2018

1 reference

Antithrombin-binding octasaccharides and role of extensions of the active pentasaccharide sequence in the specificity and strength of interaction. Evidence for very high affinity induced by an unusual glucuronic acid residue

21 January 2018

1 reference

A dose-response study in animals to evaluate the anticoagulant effect of the stage 2 unfractionated heparin USP monograph change.

21 January 2018

1 reference

Inhibition of Taq polymerase as a method for screening heparin for oversulfated contaminants

21 January 2018

1 reference

Screening of heparin API by near infrared reflectance and Raman spectroscopy

21 January 2018

1 reference

Analysis of crude heparin by (1)H NMR, capillary electrophoresis, and strong-anion-exchange-HPLC for contamination by over sulfated chondroitin sulfate.

21 January 2018

1 reference

Assay of possible economically motivated additives or native impurities levels in heparin by 1H NMR, SAX-HPLC, and anticoagulation time approaches.

21 January 2018

1 reference

Characterization of currently marketed heparin products: reversed-phase ion-pairing liquid chromatography mass spectrometry of heparin digests.

21 January 2018

1 reference

Combining (1)H NMR spectroscopy and chemometrics to identify heparin samples that may possess dermatan sulfate (DS) impurities or oversulfated chondroitin sulfate (OSCS) contaminants.

21 January 2018

1 reference

Class modeling analysis of heparin 1H NMR spectral data using the soft independent modeling of class analogy and unequal class modeling techniques

21 January 2018

1 reference

Identification of heparin samples that contain impurities or contaminants by chemometric pattern recognition analysis of proton NMR spectral data.

21 January 2018

1 reference

Detection of possible economically motivated adulterants in heparin sodium and low molecular weight heparins with a colorimetric microplate based assay

21 January 2018

1 reference

Characterization of currently marketed heparin products: adverse event relevant bioassays

21 January 2018

1 reference

Cleavage of macromolecular heparin by an enzyme from mouse mastocytoma

21 January 2018

1 reference

12 December 2020

High-throughput differentiation of heparin from other glycosaminoglycans by pyrolysis mass spectrometry

1 reference

12 December 2020

Description of hypersensitivity adverse events following administration of heparin that was potentially contaminated with oversulfated chondroitin sulfate in early 2008

1 reference

12 December 2020

Monitoring the purity of pharmaceutical heparin preparations by high-field 1H-nuclear magnetic resonance spectroscopy

1 reference

12 December 2020

Sensitive detection of oversulfated chondroitin sulfate in heparin sodium or crude heparin with a colorimetric microplate based assay

1 reference

12 December 2020

Analysis of heparin sodium by SAX/HPLC for contaminants and impurities

1 reference

12 December 2020

Heparin sodium compliance to USP monograph: structural elucidation of an atypical 2.18 ppm NMR signal

1 reference

12 December 2020

NMR of heparin API: investigation of unidentified signals in the USP-specified range of 2.12-3.00 ppm

1 reference

12 December 2020

Identifiers

DOI

10.1038/NBT.3606

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27281424%20AND%20SRC:MED&resulttype=core&format=json

13 March 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27281424%20AND%20SRC:MED&resulttype=core&format=json

13 March 2020

PubMed publication ID

27281424

1 reference